Session Date: 9th October, 2020
Session Time: 05:15 PM to 06:45 PM (IST)
Session Partner
In Partnership
Panel Members
Ashish Ahluwalia
Co-Head – Consumer, Healthcare, Food and Agri,
CDC Group
Bhuvan Srinivasan
Director,
KKR
Charles-Antoine Janssen
Co-Founder & Managing Partner,
KOIS
Jorrit Dingemans
Manager Private Equity – Fund & Co-Investments,
FMO – Dutch Development Bank
Karthikeyan T
Deputy Vice President,
Vivriti Capital
Ashish Ahluwalia
Co-Head – Consumer, Healthcare, Food and Agri,
CDC Group
Bhuvan Srinivasan
Director,
KKR
Charles-Antoine Janssen
Co-Founder & Managing Partner,
KOIS
Jorrit Dingemans
Manager Private Equity – Fund & Co-Investments,
FMO – Dutch Development Bank
Karthikeyan T
Deputy Vice President,
Vivriti Capital
Dr. Neeta Rao
Senior Health Specialist,
USAID/India
Dr. Neeta Rao
Senior Health Specialist,
USAID/India
Pompy Sridhar
Director India,
MSD for Mothers
Ranjith Menon
Executive Director,
Chiratae Ventures
Ravichandran Natrajan
Project Head,
IPE Global
Varun Jhaveri
Officer on Special Duty to the CEO,
National Health Authority (Government of India)
Pompy Sridhar
Director India,
MSD for Mothers
Ranjith Menon
Executive Director,
Chiratae Ventures
Ravichandran Natrajan
Project Head,
IPE Global
Varun Jhaveri
Officer on Special Duty to the CEO,
National Health Authority (Government of India)
Perspectives
01. India has long awaited a tech revolution in the healthcare sector: Has Covid-19 been a turning point for healthtech solutions?
02. How has COVID-19 impacted investments in healthcare? How have the rules of the game changed?
03. Healthcare Finance: How do we build customized solutions for health service providers, manufacturers and innovators
FACTS & FIGURES
Impact Investments in the healthcare sector have been slow but jumped in 2019. Healthcare has seen cumulative investment of $1.1 billion in 85 enterprises over the last decade. Impact investment funded healthcare enterprises are driving inclusive innovation across the healthcare value chain and have impacted over 34 million individuals.
KEY IMPACT IMPERATIVES
Improve access to quality primary and secondary healthcare infrastructure
Enhance affordability for quality healthcare services through effective finance
Optimize cost per health outcomes for patients.
